関連する実験動画
Updated: Sep 9, 2025

07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
8.5K
子どもにおける併発性慢性性疹: 独特の重症性フェノタイプ
International archives of allergy and immunology
|August 28, 2025
まとめ
慢性自発性疹 (CSU) と慢性誘発性疹 (CIndU) の両方を患っている子供は,より深刻な状態を示しています. このフェノタイプは,CSUまたはCIndUのみの患者と比較して,オマリズマブのような高度な治療を必要とします.
科学分野:
- 小児科
- アレルギーと免疫学
- 皮膚科
背景:
- 慢性自発性疹 (CSU) は,明らかなトリガーなしで6週間以上続く疹/血管腫を含む.
- 慢性誘発性疹 (CIndU) は,特定の環境刺激によって引き起こされる疹の独特な形態である.
- CSU と CIndU の同時発生は,孤立した型との差異化が必要となる,ユニークな臨床的課題です.
研究 の 目的:
- 同時期にCSUとCIndUを患っている小児患者の特徴を示すために.
- 同時に発生するCSU/CIndUと,孤立したCSUまたはCIndUを区別する要因を特定する.
- 合併性ウルチカリ症の子供の臨床的表型と治療の必要性を理解する.
主な方法:
- モントリオール・チルドレンズ・ホスピタルの11年間にわたって実施された前向きなコホート研究 (2013年−2024年).
- 慢性疹と診断された小児患者 (0~18歳) を含む.
- 他のCIndUタイプに焦点を当てた症状のある皮膚検査の患者を除外する.
主要な成果:
- 慢性性 ?? 病の小児患者202人中20人 (9. 9%) がCSUとCIndUの両方を患っていた.
- 併用群で最も頻繁に発生したCIndUは,冷たい疹でした (45%).
- 同時期にCSU/ CIndUを患った患者は,孤立した疹群と比較して,非制御CSU (60%) とオマリズマブ使用量 (20%) を多く示した.
結論:
- CSUとCIndUを併用した小児患者は,より重度の慢性性疹の表型を表します.
- オマリズマブなどの高度な生物学的治療が必要である.
- これらの区別を理解することは,小児性疹の適切な管理と治療戦略に不可欠です.
関連する概念動画
Allergic Reactions
28.5K
Overview
28.5K
Hypersensitivities
1.0K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
1.0K
Allergic Drug Reactions
972
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
972
Chronic Kidney Disease II: Clinical Manifestations
85
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
85
Skin Diseases and Disorders
4.1K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
4.1K
Antiasthma Drugs: Leukotriene Modifiers
461
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
461

